Here are four things to know:
1. The company expects to generate 5.5 percent to 6 percent of sales on operation basis in the third quarter of 2017.
2. Johnson & Johnson’s recent expandable cage launch is expected to add the company’s sales in the third quarter.
3. During the second quarter of 2017, Johnson & Johnson acquired Abbott Medical Optics for $4.3 billion, helping to drive sales growth. The company reported around $25 million in sales through acquired business lines for the second quarter.
4. Johnson & Johnson registered $18.8 billion in revenues in the second quarter of 2017, up around 1.6 percent year-over-year.
More articles on devices and implants:
How NICO’s BrainPath Approach & technology is ‘revolutionizing’ neurosurgery
NuVasive, Alphatec, Medtronic & more: 17 device company notes
Stryker receives $3.4M tax rebate to expand in Utah: 5 observations
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
